Skip to content

Opioid Free Anesthesia in ENT Surgery

Opioid Free Anesthesia Versus Conventional Total Intravenous Anesthesia for ENT Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04105946
Enrollment
200
Registered
2019-09-26
Start date
2022-10-31
Completion date
2023-12-31
Last updated
2022-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Endoscopic Sinus Surgery

Keywords

FESS, Opioid Free Anesthesia, Opioid Consumption

Brief summary

Opioid Free Anesthesia (OFA) - which has been applied mainly in bariatric surgery - has begun to receive more and more attention and to obtain fanatical supporters versus conventional anesthesia. The advantages of this type of anesthesia are mainly achieved by the action and effect of the various drugs that compose it. Functional Endoscopic Sinus Surgery is performed in cases where sinusitis or its complications are difficult to treat with medication. With special cameras and endoscopes, the narrow anatomical regions of the sinus can be depicted and precisely surgically approached. Usually surgery is conducted under general anesthesia. According to the literature, total intravenous anesthesia should be used for sinus surgery to achieve blood pressure control as well as controlled hypotension to prevent intraoperative bleeding. Most of the studies agree that the best type of anesthesia for this type of surgery is total intravenous anesthesia. When it comes to Opioid Free Anesthesia in FESS, there are not many studies, except of some studies that don't use solely Opioid Free Anesthesia but some of the drugs that consist it. Patients scheduled for elective Functional Endoscopic Sinus Surgery will be randomised in two groups. One receiving OFA and one receiving TIVA.

Interventions

DRUGDexmedetomidine

dexmedetomidine administration intraoperatively in combination with other drugs used in OFA

DRUGRemifentanil

remifentanil administration intraoperatively in combination with other drugs used in TIVA

Sponsors

University of Thessaly
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients 18 - 75 years old * Elective FESS

Exclusion criteria

1. Patients \< 18 or \>75 years of age 2. Patients who can't read of speak the Greek language 3. Patients with psychiatric disorders 4. Patients with atrioventricular block in ECG 5. Patients with musculoskeletal disorders 6. Patients with coronary artery disease 7. Patients uncapable of giving informed consent

Design outcomes

Primary

MeasureTime frameDescription
Pain management48 hoursVisual Analogue Scale score for pain after FESS
Intraoperative bleeding in the surgical fieldintraoperativelySurgeon bleeding scale 0-3 for bleeding in the operative field

Secondary

MeasureTime frameDescription
Patient Satisfaction48 hoursQuality of recovery questionnaire for patient satisfaction

Countries

Greece

Contacts

Primary ContactMetaxia Bareka, MD, PhD
barekametaxia@hotmail.com+306947845083
Backup ContactDimitra Papaspirou, MD
dimitra.papaspyrou@hotmail.com+306982004382

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026